Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria
Open Access
- 1 December 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 13 (5), 457-462
- https://doi.org/10.1038/sj.gt.3302678
Abstract
Novel recombinant adeno-associated virus vectors pseudotyped with serotype 8 capsid (rAAV2/8) have recently shown exciting promise as effective liver-directed gene transfer reagents. We have produced a novel liver-specific rAAV2/8 vector expressing the mouse phenylalanine hydroxylase (Pah) cDNA and have administered this vector to hyperphenylalaninemic PAH-deficient Pahenu2 mice, a model of human phenylketonuria (PKU). Our hypothesis was that this vector would produce sufficient hepatocyte transduction frequency and PAH activity to correct blood phenylalanine levels in murine PKU. Portal vein injection of recombinant AAV2/8 vector into five adult Pahenu2 mice yielded complete and stable (up to 17 weeks) correction of serum phenylalanine levels. Liver PAH activity was corrected to 11.5±2.4% of wild type liver activity and was associated with a significant increase in phenylalanine clearance following parenteral phenylalanine challenge. Although questions of long-term safety and stability of expression remain, recombinant AAV2/8-mediated, liver-directed gene therapy is a promising novel treatment approach for PKU and allied inborn errors of metabolism.Keywords
This publication has 30 references indexed in Scilit:
- Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transferGene Therapy, 2005
- Low Therapeutic Threshold for Hepatocyte Replacement in Murine PhenylketonuriaMolecular Therapy, 2005
- Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in MiceJournal of Virology, 2005
- 878. Correction of Maternal Phenylketonuria Syndrome in the Pahenu2 Missense Mutant Mouse by r-AAV Mediated Gene TherapyMolecular Therapy, 2004
- Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria miceGene Therapy, 2004
- Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotypeBlood, 2004
- Chromosomal effects of adeno-associated virus vector integrationNature Genetics, 2002
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient miceSomatic Cell and Molecular Genetics, 1992
- Competitive Inhibition of Mammalian Tyrosinase by Phenylalanine and its Relationship to Hair Pigmentation in PhenylketonuriaNature, 1957